Germany’s Merck KGaA is facing a big hole in its late-stage pipeline after multiple sclerosis (MS) candidate evobrutinib missed the mark in two phase 3 trials, spelling the end of the programme ...

Sanam Saeedi was devastated by her MS diagnosis, but resolved not to lose hope and decided not to allow MS to take everything ...

On Saturday, March 1st, 2025, at about 6:56pm, officers with the Hope Police Department arrested Nyla Muldrew, 22 of Hope in ...